Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2015 Q1- Text added to 2015 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
AbbVie, ACWY, Alkaline, Allergan, Authorisation, Biotechnology, Chantix, CMA, commensurate, commonly, communicated, complementary, coupled, delivery, Denmark, dietary, disputed, Dutch, Geodon, Greek, Humira, index, inflammatory, introduced, Iraq, Israel, Kidney, krone, lira, MA, mandatory, Mencevax, Nimenrix, opposed, phenytoin, Phosphatase, procedural, quadrivalent, quantity, RAR, recAP, recombinant, retiree, sickle, sodium, subsidy, tender, Turkish, UK
Removed:
Amgen, attributed, await, California, capitalize, conditional, Congressional, dramatic, Embeda, exact, formula, ibuprofen, identification, India, influence, inform, intent, investee, maintaining, met, naproxen, NRT, overridden, physician, pneumoniae, PRECISION, proportional, representation, SGR, translated, veto, widespread
Valuein 2015 Q1 filing- Value in 2015 Q2 filing
Original filings
Filing view